Logo image
Adaptation of SARS-CoV-2 to ACE2 H353K mice reveals new spike residues that drive mouse infection
Journal article   Open access   Peer reviewed

Adaptation of SARS-CoV-2 to ACE2 H353K mice reveals new spike residues that drive mouse infection

Kun Li, Abhishek Verma, Pengfei Li, Miguel E Ortiz, Grant M Hawkins, Nicholas J Schnicker, Peter J Szachowicz, Alejandro Pezullo, Christine L Wohlford-Lenane, Tom Kicmal, …
Journal of virology, Vol.98(1), e0151023
01/23/2024
DOI: 10.1128/jvi.01510-23
PMCID: PMC10804960
PMID: 38168680
url
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10804960View
Published (Version of record) Open Access

Abstract

We developed a new mouse model with a humanized angiotensin converting enzyme 2 (ACE2) locus that preserves native regulatory elements. A single point mutation in mouse ACE2 (H353K) was sufficient to confer infection with ancestral severe acute respiratory syndrome-coronavirus-2 virus. Through serial passage, a virulent mouse-adapted strain was obtained. In aged mACE2H353K mice, the mouse-adapted strain caused diffuse alveolar disease. The mouse-adapted virus also infected standard BALB/c and C57BL/6 mice, causing severe disease. The mouse-adapted virus acquired five new missense mutations including two in spike (K417E, Q493K), one each in nsp4, nsp9, and M and a single nucleotide change in the 5' untranslated region. The Q493K spike mutation arose early in serial passage and is predicted to provide affinity-enhancing molecular interactions with mACE2 and further increase the stability and affinity to the receptor. This new model and mouse-adapted virus will be useful to evaluate COVID-19 disease and prophylactic and therapeutic interventions.
Pathogenesis SARS-CoV-2 coronavirus mouse-adapted virus

Details

Metrics

Logo image